Comment period closing · Food and Drug Administration · Aug 3FDAClosed
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Revised Draft Guidance for Industry
Health-care pricing, access, provider rules, and delivery-system reform not specific to a program.